Imagine receiving your mammogram results and being told you have dense breast tissue—a term that might sound unfamiliar but carries significant implications. But here’s where it gets controversial: a recent study suggests that sharing this information could actually leave women feeling more anxious and confused than informed. Could this well-intentioned practice be doing more harm than good?
Breast density refers to the ratio of glandular and fibrous tissue to fatty tissue in the breasts. It’s a known risk factor for breast cancer and can complicate mammogram readings, making it harder to detect abnormalities. In Australia, women are already informed of their breast density during screenings, and the UK’s National Screening Committee (NSC) is considering adopting this practice. But is this transparency truly beneficial?
A study conducted by researchers at the University of Sydney and published in the BMJ sheds light on this issue. The team analyzed data from 2,401 Australian women screened for breast cancer between September 2023 and July 2024, all of whom had dense breasts. These women were divided into three groups: a control group not informed of their breast density, a group notified via written information, and a group provided with a link to an online video explanation. After eight weeks, participants were surveyed about their psychological responses and intentions to seek further medical advice.
And this is the part most people miss: Women who were informed about their breast density reported higher levels of anxiety and confusion compared to the control group. Yet, they were also more likely to consult their GP about their results—22.8% and 19.4% in the informed groups versus 12.9% in the control group. This raises a critical question: Does the potential for increased medical engagement outweigh the emotional toll?
Sophie Brooks, a health information manager at Cancer Research UK, notes that while dense breasts can complicate cancer detection, it’s not a factor individuals can control or self-assess. She emphasizes the study’s mixed findings, highlighting the need for clearer communication and support. “More research is essential to determine whether informing women about breast density is ultimately beneficial,” she adds. The UK NSC is currently investigating this issue, but the debate remains far from settled.
The study’s conclusion is striking: Women informed of their dense breasts felt anxious and confused, did not feel empowered to make decisions about their breast health, and sought guidance primarily from their GPs. Melanie Sturtevant of Breast Cancer Now underscores the importance of understanding how such information impacts mental health. “While knowing personal risk factors could enable informed decisions, studies like this remind us of the delicate balance between awareness and emotional well-being,” she explains.
In the UK, routine screening does not currently include breast density assessments, and a review of whether additional screening should be offered to women with dense breasts is ongoing. Advocates like Sturtevant urge the UK NSC to proceed with urgency and transparency, ensuring that any changes prioritize both physical and mental health.
Here’s the thought-provoking question: Should healthcare providers prioritize transparency about breast density, even if it risks causing anxiety, or should they focus on providing clear, supportive guidance first? Share your thoughts in the comments—this is a conversation that needs your voice.
